Ischaemic disorders are leading causes of morbidity and mortality worldwide. While the
current therapeutic approaches have improved life expectancy and quality of life, they are …

Stem cells (SCs) have been used therapeutically for decades, yet their applications are
limited by factors such as the risk of immune rejection and potential tumorigenicity …

The field of extracellular vesicle (EV) signalling has the potential to transform our
understanding of maternal-fetal communication and affords new opportunities for non …

Extracellular vesicles (EVs) are released by all cells and contribute to cell‐to‐cell
communication. The capacity of EVs to target specific cells and to efficiently deliver a …

Mesenchymal stem cells (MSCs) have demonstrated potential in both clinical and pre-
clinical research for mitigating tissue damage and inflammation associated with acute …

Exosomes, which are tiny particles released by cells, have the ability to transport various
molecules, including proteins, lipids, and genetic material containing non-coding RNAs …

Acute pancreatitis (AP) often leads to a high incidence of cardiac injury, posing significant
challenges in the treatment of severe AP and contributing to increased mortality rates …

Exosomes exhibit high bioavailability, biological stability, targeted specificity, low toxicity,
and low immunogenicity in shuttling various bioactive molecules such as proteins, lipids …

Extracellular vesicles (EVs) have the innate ability to carry proteins, lipids, and nucleic acids
between cells, and thus these vesicles have gained much attention as potential therapeutic …

Intracerebral hemorrhage (ICH) is associated with secondary neuroinflammation, leading to
severe central nervous system damage. Exosomes derived from human adipose-derived …